Tempus Wealth Planning, LLC
- SEC CIK
- 0001806428
- Latest filing
- Jul 22, 2026
The latest 13F from Tempus Wealth Planning, LLC covers Q2 2026 (filed Jul 22, 2026): 281 long positions worth $511.0M. The top 10 holdings make up 28.0% of the portfolio, and the largest is General Electric Co (GE) at 6.4%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 30
- Est. +$21.1M
- Added
- 135
- Est. +$33.1M
- Reduced
- 94
- Est. −$27.9M
- Sold out
- 18
- Est. −$8.27M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
- ProShares Tr74347R206+$3.11MNew
- ProShares Tr74347R107+$3.10MNew
- State Street SPDR Portfolio S&P 500 ETF78464A854+$2.85MAdded
- JPMorgan Ultra-Short Income ETF46641Q837+$2.75MAdded
- ProShares Tr74347R842+$2.24MNew
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- GEGeneral Electric Co
- ProShares Tr74347R206+0.61 pp0.0% → 0.6%
- ProShares Tr74347R107+0.61 pp0.0% → 0.6%
- JPMorgan Ultra-Short Income ETF46641Q837+0.53 pp<0.1% → 0.6%
- State Street SPDR Portfolio S&P 500 ETF78464A854+0.53 pp1.2% → 1.7%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
- State Street SPDR Bloomberg 1-3 Month T-Bill ETF78468R663−$3.89MReduced
- iShares Ibonds 2026 Term High Yield and Income ETF46436E528−$3.66MReduced
- Invesco Exchange Traded FD T46137V100−$2.88MReduced
- Gmo ETF Trust90139K407−$2.27MReduced
- Tidal Trust I886364231−$1.38MReduced
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
- State Street SPDR Bloomberg 1-3 Month T-Bill ETF78468R663−1.01 pp1.7% → 0.7%
- iShares Ibonds 2026 Term High Yield and Income ETF46436E528−0.91 pp1.2% → 0.3%
- Invesco Exchange Traded FD T46137V100−0.64 pp0.8% → 0.2%
- Gmo ETF Trust90139K407−0.52 pp0.7% → 0.1%
- iShares Tr464288877−0.30 pp0.5% → 0.2%
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $511.0M
- +$76.0M (+17.5%) vs. prior quarter
- Positions
- 281
- +12 vs. prior quarter
- Top 10 concentration
- 28.0%
- Top 10 as share of value
- Turnover
- 7.6%
- Q2 2026, one quarter
- Average holding period
- 13.7 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $511.0M (Q2 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 22, 2026 | 281 | $511.0M | GEGEVCapital Group Dividend Value | vs. Q1 2026 | SEC |
| Q1 2026 | Apr 29, 2026 | 269 | $435.0M | GEGEVNVDA | vs. Q4 2025 | SEC |
| Q4 2025 | Jan 16, 2026 | 275 | $436.5M | GEGEVNVDA | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 6, 2025 | 276 | $435.7M | GEGEVNVDA | vs. Q2 2025 | SEC |
| Q2 2025 | Jul 17, 2025 | 259 | $401.2M | GENVDAGEV | vs. Q1 2025 | SEC |
| Q1 2025 | May 6, 2025 | 252 | $334.8M | GENVDAMSFT | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 24, 2025 | 247 | $327.4M | GENVDAMSFT | vs. Q3 2024 | SEC |
| Q3 2024 | Oct 22, 2024 | 220 | $273.0M | GENVDAMSFT | vs. Q2 2024 | SEC |
| Q2 2024 | Jul 25, 2024 | 206 | $239.4M | GEMSFTNVDA | vs. Q1 2024 | SEC |
| Q1 2024 | Apr 19, 2024 | 191 | $227.3M | GEMSFTState Street SPDR Bloomberg 1-3 Month T-Bill ETF | vs. Q4 2023 | SEC |
| Q4 2023 | Jan 24, 2024 | 192 | $227.8M | GEiShares TrAAPL | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 1, 2023 | 167 | $199.5M | iShares TrGEAAPL | vs. Q2 2023 | SEC |
| Q2 2023 | Jul 21, 2023 | 185 | $221.6M | iShares TrGEMSFT | vs. Q1 2023 | SEC |
| Q1 2023 | May 8, 2023 | 177 | $204.6M | iShares TrGEMSFT | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 10, 2023 | 181 | $164.6M | GEMSFTAAPL | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 179 | $149.9M | iShares TrMSFTAAPL | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 5, 2022 | 127 | $121.6M | iShares TrSPDR Series TrustGE | vs. Q1 2022 | SEC |
| Q1 2022 | May 6, 2022 | 139 | $140.6M | iShares TrMSFTAAPL | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 2, 2022 | 149 | $185.4M | iShares TrGEMSFT | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 9, 2021 | 150 | $176.5M | iShares TrGESPDR Series Trust | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 12, 2021 | 145 | $150.7M | GESPDR Series TrustMSFT | vs. Q1 2021 | SEC |
| Q1 2021 | Apr 29, 2021 | 97 | $94.5M | GESPDR Series TrustSPDR Series Trust | – | SEC |